- Andersson M K, Anissian L, Stark A, Bucht E, Fellander-Tsai L, Tsai J A. Synovial fluid from loose hip arthroplasties inhibits human osteoblasts. Clin Orthop 2000; 378: 148–54
- Atkins R M, Langkamer V G, Perry M J, Elson C J, Collins C M. Bone-membrane interface in aseptic loosening of total joint arthroplasties. J Arthroplasty 1997; 12: 461–4
- Bautista C M, Baylink D J, Mohan S. Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. Biochem Biophys Res Commun 1991; 176: 756–63
- Chiba J, Rubash H E. Letter to the editor. Clin Orthop 1994; 309: 278
- Engelbrecht E, Heinert K. Klassifikation und Behandlung-asrichtlinien von Knochensubstanzverlusten bei Revision-soperationen am Huftgelenk. Hrsg Endoklinik Hamburg. Springer-Verlag, Berlin 1987; 190–201
- Honda Y, Landale E C, Strong D D, Baylink D J, Mohan S. Recombinant synthesis of insulin-like growth factor-binding protein-4 (IGFBP-4): Development, validation, and application of a radioimmunoassay for IGFBP-4 in human serum and other biological fluids. J Clin Endocrinol Metab 1996; 81: 1389–96
- Hwa V, Oh Y, Rosenfeld R G. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 1999; 20: 761–87
- Juul A. Serum levels of insulin-like growth factors I and its binding proteins in health and disease. Growth Horm IGF Res 2003; 13: 113–70
- Kanety H, Shimon I, Ehrenfeld M, Israeli A, Pariente C, Karasik A. Insulin-like growth factor I and its binding proteins 3 and 4 are increased in human inflammatory synovial fluid. J Rheumatol 1996; 23: 815–8
- Kiefer M C, Schmid C, Waldvogel M, Schlapfer I, Futo E, Masiarz F R, Barr P J, Zapf J. Recombinant human insulin-like growth factor binding proteins 4, 5, and 6: biological and physiochemical characterization. Growth Regul 1993; 3: 56–9
- Kim K J, Rubash H E, Wilson S C, D'Antontio J A, McClain E J. A histologic and biochemical comparison of interface tissues in cementless and cemented hip prostheses. Clin Orth 1993; 287: 142–52
- Malpe R, Baylink D J, Linkhart T A, Wergedal J E, Mohan S. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent. J Bone Miner Res 1997; 12: 423–30
- Matsui H, Shimizu M, Tsuji H. Cartilage and subchondral bone interaction in osteoarthrosis of human knee joint: a histological and histomorphometric study. Microsc Res Tech 1997; 37: 333–42
- Matsumoto T, Gargosky S E, Iwasaki K, Rosenfeld R G. Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid. J Clin Endocrinol Metab 1996; 81: 150–5
- Mohan S, Baylink D J. Growth factors. Clin Orthop 1991; 263: 30–8
- Mohan S, Baylink D J. Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: comparison with acid-ethanol treatment and C18 Sep-Pak separation. J Clin Endocrinol Metab 1995; 80: 637–47
- Mohan S, Bautista C M, Herring S J, Linkhart T A, Baylink D J. Development of valid methods to measure insulin-like growth factors-I and -II in bone cell-conditioned medium. Endocrinology 1990; 126: 2534–42
- Mohan S, Libanati C, Dony C, Lang K, Srinavasan N, Baylink D J. Development, validation, and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids. J Clin Endocrinol Metab 1995a; 80: 2638–45
- Mohan S, Nakao Y, Honda Y, Landale E, Leser U Dony C, Lang K, Baylink D J. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 1995b; 270: 20424–31
- Sabokbar A, Rushton N. Role of inflammatory mediators and adhesion molecules in the pathogenesis of aseptic loosening in total hip arthroplasties. J Arthroplasty 1995; 10: 810–6
- Schiltz P M, Mohan S, Baylink D J. Insulin-like growth factor binding protein-4 inhibits both basal and IGF-mediated chick pelvic cartilage growth in vitro. J Bone Miner Res 1993; 8: 391–6
- Schmid C, Schlapfer I, Keller A, Waldvogel M, Froesch E R, Zapf J. Effects of insulin-like growth factor (IGF) binding proteins (BPs) -3 and -6 on DNA synthesis of rat osteoblasts: further evidence for a role of auto-/paracrine IGF I but not IGF II in stimulating osteoblast growth. Biochem Biophys Res Commun 1995; 212: 242–8
- Schmid C, Schlapfer I, Gosteli-Peter M A, Froesch E R, Zapf J. Effects and fate of human IGF-binding protein-5 in rat osteoblast cultures. Am J Physiol 1996; 271: 1029–35
- Schneiderman R, Rosenberg N, Hiss J, Lee P, Liu F, Hinz R L, Maroudas A. Concentration and size distribution of insulin-like growth factor-I in human normal and osteoarthritic synovial fluid and cartilage. Arch Biochem Biophys 1995; 324: 173–88
- Shimasaki S, Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res 1991; 3: 243–66
- Srinivasan N, Edwall D, Linkhart T A, Baylink D J, Mohan S. Insulin-like growth factor-binding protein-6 produced by human PC-3 prostate cancer cells: isolation, characterization and its biological action. J Endocrinol 1996; 149: 297–303
- Yan T, Wegedal, Zhou Y, Mohan S, Baylink D J, Strong D D. Inhibition of human osteoblast marker gene expression by retinoids is mediated in part by insuline-like growth factor binding protein-6. Growth Horm IGF Res 2001; 11: 368–77
Acta Orthopaedica
Volume 76, 2005 - Issue 3